Team:Yale/Project

From 2013.igem.org

(Difference between revisions)
(2013 Project Overview)
(2013 Project Overview)
Line 11: Line 11:
QQQQQ TO BE CONTINUED QQQQQQ
QQQQQ TO BE CONTINUED QQQQQQ
-
== '''2013 Project Overview''' ==
 
-
 
-
We aim to develop an orthogonal translation system for selective incorporation of selenocysteine, a non-standard amino acid, in E. coli and use the system to produce a more effective heavy metal biosorbent.
 
-
 
-
=== '''Project Background''' ===
 
-
 
-
In 2011,  Dr. Farren Isaacs and others reported progress on replacing all TAG stop codons with TAA in Escherichia coli, enabling reassignment of the TAG codon. (Isaacs et al. 2011). Dr. Isaacs has recently completed this work, creating the first genomically-recoded organism with an unassigned codon (Lajoie, M. J et al. 2013. Science. In press.).
 
-
 
-
This  genome-wide recoding was enabled by lambda-Red recombineering (Sharan et al. 2009) and multiplex automated genome engineering (Wang et al. 2009). λ-Red recombineering uses the lambda prophage protein Beta to mediate the homologous recombination of an exogenous single-stranded oligonucleotide, delivered into the cell by electroporation, with the host genome, by annealing that oligonucleotide to single-stranded genomic DNA exposed on the lagging strand of the replication fork (Ellis et al. 2001). A 30-bp region of homology at either end of a sequence is sufficient to drive recombination of the entire strand, including mismatched regions, and mismatches thus incorporated are passed to progeny at high efficiency (up to 30%) in strains lacking methyl-directed mismatch repair (ΔmutS; Constantino & Court 2003).
 
-
 
-
QQQQQ TO BE CONTINUED QQQQQQ
 

Revision as of 19:47, 10 June 2013


Contents

2013 Project Overview

We aim to develop a more efficient method for the biosynthesis of poly(lactic acid) from E. coli through the use of multiplex automated genome engineering. We hope this method will lower both the economic and environmental costs of synthesizing PLA in such a way as to revolutionize the biomaterials industry.

Project Background

QQQQQ TO BE CONTINUED QQQQQQ




Part 2

The Experiments

Part 3

Results